Strides Pharma suspends sale of Ranitidine tab in US

"While the company conducts the relevant tests mandated by the the United States Food and Drug Administration (USFDA), it has suspended sales of Ranitidine tablets in the US market until such time it has clarity of next steps as would be indicated by the USFDA," Strides Pharma Science said in a BSE filing.

from Moneycontrol Business News https://ift.tt/2maTrjh